Targeting the fibroblast growth factor receptor 2 in gastric cancer: promise or pitfall? - Wikidata - wikimedia - TriplyDB

Targeting the fibroblast growth factor receptor 2 in gastric cancer: promise or pitfall?

Targeting the fibroblast growth factor receptor 2 in gastric cancer: promise or pitfall?

http://www.wikidata.org/entity/Q38741697

about

Multicenter phase II study of apatinib treatment for metastatic gastric cancer after failure of second-line chemotherapy.What's New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives

P2860

Q47109075-217B512D-579C-45EE-860F-96F2AC993995 Q57159608-086A661E-9621-47B5-8060-81BA7E5D2E1C

P2860

Targeting the fibroblast growth factor receptor 2 in gastric cancer: promise or pitfall?

http://www.wikidata.org/entity/Q38741697

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Targeting the fibroblast growth factor receptor 2 in gastric cancer: promise or pitfall?

@en

type

label

Targeting the fibroblast growth factor receptor 2 in gastric cancer: promise or pitfall?

@en

prefLabel

Targeting the fibroblast growth factor receptor 2 in gastric cancer: promise or pitfall?

@en

P1433

Q38741697-4B371063-3E22-4EEB-89C7-8D50228D48B2

P1476

Q38741697-1D2CCC38-E450-4997-838E-E43DA1D5BF4E

P2093

Q38741697-53B01B19-F046-4DF6-8B33-4BDFEBC3056A

Q38741697-55BA8C8B-C10F-4016-9915-09D91466CEB3

Q38741697-684BEA19-A0D8-497F-BFF9-6F6380AB362A

Q38741697-A7872333-B93F-4F25-979C-50268CD4FC7A

P2860

Q38741697-0EAC66FC-E5D6-45F6-AF4F-6F7C514CA76E

Q38741697-221A9012-23BC-4749-9A28-B219C4956E0E

Q38741697-2A44B5A2-8EBF-4862-A185-6CFB2B720BA9

Q38741697-2B13B00C-DE64-44A2-AFC7-466596B46F75

Q38741697-2EF63004-BFAE-4B6D-8754-31A6E990DFE2

Q38741697-2FEA7FCE-08BE-4701-ADCD-592749088A67

Q38741697-3227BABD-005D-4D1A-981E-20E97B05B2C8

Q38741697-361BC36D-6C99-48F2-9000-CDEB34315671

Q38741697-3FBA42B0-B48F-4267-AF81-03F7A82DE039

Q38741697-46D05603-E2F8-4FB9-B72D-8C618C956155

P304

Q38741697-179379CA-C7C3-46AC-92DD-D51E141ADC17

P31

Q38741697-5E47297A-A422-4858-BB7C-306E0BFAA0BE

P356

Q38741697-8633AC80-DB04-4D7F-8BF2-B96597AFEB7D

P433

Q38741697-BE364AF4-B1E4-4C72-BC34-E6B2DC9763FB

P478

Q38741697-B45E818B-2F26-4A97-9010-57C10B70F751

P50

Q38741697-0123BACD-A22A-4C72-8416-2580549957A2

Q38741697-06A1C63A-F4AF-49BB-88CF-7EEC348A65EE

P577

Q38741697-1A1F68B1-12BC-40FA-BD6F-ED79D8F863B4

P698

Q38741697-0328DCD2-20FA-4787-8182-868B1174390F

P356

P1433

Annals of Oncology

P1476

Targeting the fibroblast growth factor receptor 2 in gastric cancer: promise or pitfall?

@en

P2093

C Hierro

http://www.w3.org/2001/XMLSchema#string

J Rodon

http://www.w3.org/2001/XMLSchema#string

M Alsina

http://www.w3.org/2001/XMLSchema#string

M Sánchez

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors

Quantification of HER family receptors in breast cancer

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.

Comprehensive molecular characterization of gastric adenocarcinoma

Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors

Fibroblast growth factor signalling: from development to cancer

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

P304

1207-1216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDX081

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Josep Tabernero

P577

2017-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28327938

http://www.w3.org/2001/XMLSchema#string